NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	24/12/2020
Target sample size	33
Countries of recruitment	North America,Europe,Japan,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Ramucirumab Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Gemcitabine Therapeutic category code : 422 Antimetabolic agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Docetaxel Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	efficacy pharmacokinetics safety pharmacodynamics other

Key inclusion & exclusion criteria

Age minimum	>= 12month old
Age maximum	<= 29age old
Gender	Both
Include criteria
Exclude criteria